BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sarris J, Pinzon Rubiano D, Day K, Galvão-Coelho NL, Perkins D. Psychedelic medicines for mood disorders: current evidence and clinical considerations. Curr Opin Psychiatry 2022;35:22-9. [PMID: 34855694 DOI: 10.1097/YCO.0000000000000759] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Temizer R, Chen YW, Aoki C. Individual differences in the positive outcome from adolescent ketamine treatment in a female mouse model of anorexia nervosa involve drebrin A at excitatory synapses of the medial prefrontal cortex. Synapse 2023;77:e22253. [PMID: 36121749 DOI: 10.1002/syn.22253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Pilc A, Machaczka A, Kawalec P, Smith JL, Witkin JM. Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism. Expert Opin Drug Discov 2022;17:1131-46. [PMID: 35934973 DOI: 10.1080/17460441.2022.2111415] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kargbo RB. 5-HT Receptor Modulators for Therapeutic Use in the Treatment of Obsessive-Compulsive Disorder and Other Psychological Disorders. ACS Med Chem Lett 2022;13:770-2. [PMID: 35586441 DOI: 10.1021/acsmedchemlett.2c00153] [Reference Citation Analysis]
4 Kargbo RB. 3-Pyrrolidine-indole Derivatives as 5-HT2-Selective Receptor Modulators for the Potential Treatment of Mental Disorders. ACS Med Chem Lett 2022;13:749-51. [PMID: 35586424 DOI: 10.1021/acsmedchemlett.2c00128] [Reference Citation Analysis]
5 Bravender T. 50 Years Ago in TheJournalofPediatrics: Accidental Ingestion of LSD: Everything Old Is New Again. J Pediatr 2022;244:57. [PMID: 35534163 DOI: 10.1016/j.jpeds.2022.01.020] [Reference Citation Analysis]
6 Kargbo RB. Improved Metabolically Stable 5-HT Receptor Modulators and the Development of New Antidepressants. ACS Med Chem Lett 2022;13:537-9. [PMID: 35450349 DOI: 10.1021/acsmedchemlett.2c00129] [Reference Citation Analysis]
7 Mills PJ, Bushell WC. Returning Wholeness to Health. Glob Adv Health Med 2022;11:2164957X2210923. [DOI: 10.1177/2164957x221092358] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ionescu TM, Amend M, Watabe T, Hatazawa J, Maurer A, Reischl G, Pichler BJ, Wehrl HF, Herfert K. Neurovascular Uncoupling: Multimodal Imaging Delineates the Acute Effects of MDMA.. [DOI: 10.1101/2022.02.14.480365] [Reference Citation Analysis]
9 Huang J, Pham M, Panenka WJ, Honer WG, Barr AM. Chronic Treatment With Psilocybin Decreases Changes in Body Weight in a Rodent Model of Obesity. Front Psychiatry 2022;13:891512. [PMID: 35664477 DOI: 10.3389/fpsyt.2022.891512] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 López-Arnau R, Camarasa J, Carbó ML, Nadal-Gratacós N, Puigseslloses P, Espinosa-Velasco M, Urquizu E, Escubedo E, Pubill D. 3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs. Front Psychiatry 2022;13:990405. [PMID: 36262632 DOI: 10.3389/fpsyt.2022.990405] [Reference Citation Analysis]
11 de Sousa GM, de Oliveira Tavares VD, de Menezes Galvão AC, de Almeida RN, Palhano-Fontes F, Lobão-Soares B, de Morais Freire FA, Nunes EA, Maia-de-Oliveira JP, Perkins D, Sarris J, de Araujo DB, Galvão-Coelho NL. Moderators of ayahuasca's biological antidepressant action. Front Psychiatry 2022;13:1033816. [PMID: 36545037 DOI: 10.3389/fpsyt.2022.1033816] [Reference Citation Analysis]